PL1730315T3 - Polimorfizmy w genie NOD2/CARD15 - Google Patents

Polimorfizmy w genie NOD2/CARD15

Info

Publication number
PL1730315T3
PL1730315T3 PL05736111T PL05736111T PL1730315T3 PL 1730315 T3 PL1730315 T3 PL 1730315T3 PL 05736111 T PL05736111 T PL 05736111T PL 05736111 T PL05736111 T PL 05736111T PL 1730315 T3 PL1730315 T3 PL 1730315T3
Authority
PL
Poland
Prior art keywords
nod2
polymorphisms
card15 gene
methods
card15
Prior art date
Application number
PL05736111T
Other languages
English (en)
Inventor
Hanns-Georg Klein
Original Assignee
Klein Hanns Georg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klein Hanns Georg filed Critical Klein Hanns Georg
Publication of PL1730315T3 publication Critical patent/PL1730315T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL05736111T 2004-03-27 2005-03-29 Polimorfizmy w genie NOD2/CARD15 PL1730315T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004015143 2004-03-27
EP05736111A EP1730315B1 (de) 2004-03-27 2005-03-29 Polymorphismen im nod2/card15 gen
PCT/DE2005/000550 WO2005095640A1 (de) 2004-03-27 2005-03-29 Polymorphismen im nod2/card15 gen

Publications (1)

Publication Number Publication Date
PL1730315T3 true PL1730315T3 (pl) 2010-03-31

Family

ID=34965877

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05736111T PL1730315T3 (pl) 2004-03-27 2005-03-29 Polimorfizmy w genie NOD2/CARD15

Country Status (9)

Country Link
US (1) US7803535B2 (pl)
EP (1) EP1730315B1 (pl)
AT (1) ATE446385T1 (pl)
DE (2) DE112005001317A5 (pl)
DK (1) DK1730315T3 (pl)
ES (1) ES2336581T3 (pl)
PL (1) PL1730315T3 (pl)
SI (1) SI1730315T1 (pl)
WO (1) WO2005095640A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12110555B2 (en) 2004-12-08 2024-10-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US20100015156A1 (en) * 2007-03-06 2010-01-21 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
CA2779750C (en) 2009-11-06 2019-03-19 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
AR085091A1 (es) 2011-01-26 2013-09-11 Kolltan Pharmaceuticals Inc Anticuerpos anti-kit y sus usos
RU2681730C2 (ru) 2012-07-25 2019-03-12 Селлдекс Терапьютикс Инк. Антитела против kit и их применения
KR101530535B1 (ko) * 2013-06-13 2015-06-23 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
CN113908269A (zh) 2014-05-23 2022-01-11 塞尔德克斯医疗公司 嗜酸性粒细胞或肥大细胞相关病症的治疗
KR101541139B1 (ko) 2015-02-13 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541140B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101593090B1 (ko) * 2015-06-25 2016-02-12 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541142B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541141B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002243415B2 (en) 2000-10-30 2007-05-24 Regents Of The University Of Michigan Nod2 nucleic acids and proteins
US7205107B2 (en) 2001-12-21 2007-04-17 Cytokine Pharmasciences, Inc. Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

Also Published As

Publication number Publication date
ES2336581T3 (es) 2010-04-14
SI1730315T1 (sl) 2010-02-26
ATE446385T1 (de) 2009-11-15
EP1730315A1 (de) 2006-12-13
WO2005095640B1 (de) 2006-03-09
DK1730315T3 (da) 2010-03-08
WO2005095640A1 (de) 2005-10-13
DE112005001317A5 (de) 2007-05-24
DE502005008373D1 (de) 2009-12-03
US20070212694A1 (en) 2007-09-13
EP1730315B1 (de) 2009-10-21
US7803535B2 (en) 2010-09-28

Similar Documents

Publication Publication Date Title
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2005059108A3 (en) Gene expression profiles and methods of use
PT1597391E (pt) Utilização de arn intrónico para medir a expressão genética
SI1730315T1 (sl) Polimorfizmi v genu NOD2/CARD15
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2006037064A3 (en) Mutant polymerases for sequencing and genotyping
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
WO2009059317A3 (en) Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
WO2001077164A3 (en) Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
WO2008061213A3 (en) Genetic variations associated with tumors
WO2010018601A3 (en) Genetic variants predictive of cancer risk
SG142154A1 (en) Methods for genomic analysis
WO2005014850A3 (en) Systems and methods for analyzing nucleic acid sequences
WO2005032495A8 (en) Gene expression profiles and methods of use
MX2007009809A (es) Amplificacion de sonda por seleccion.
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
WO2008112903A3 (en) Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
WO2006037462A3 (en) Cancer markers
WO2007120955A3 (en) Genes affecting human memory performance
WO2007058968A3 (en) Gene expression profiles and methods of use
MX2009004382A (es) Variaciones geneticas asociadas con tumores.
WO2008048902A3 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
WO2010014905A3 (en) Polymorphisms in the xbp-1 gene associated with inflammatory bowel disease
UA93658C2 (en) Cell surface glycoprotein
NZ576349A (en) Equine performance test